Sign In

Login

Password

Forgot Password ? Sign Up

Ambroxol (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ambroxol" in German language version.

refsWebsite
Global rank German rank
17doi.org
2nd place
3rd place
6nih.gov
4th place
7th place
3espacenet.com
800th place
160th place
2karger.com
4,489th place
3,288th place
1sigmaaldrich.com
924th place
87th place
1web.archive.org
1st place
1st place
1mmp-online.de
low place
low place
1unipv.it
low place
low place
1kobv.de
low place
1,305th place
1aspetjournals.org
6,663rd place
4,062nd place
1egms.de
low place
5,193rd place

aspetjournals.org

molpharm.aspetjournals.org

  • Thomas Weiser, Nicola Wilson: Inhibition of Tetrodotoxin (TTX)-Resistant and TTX-Sensitive Neuronal Na+ Channels by the Secretolytic Ambroxol. In: Molecular Pharmacology. Band 62, Nr. 3, 1. September 2002, S. 433–438, doi:10.1124/mol.62.3.433, PMID 12181417 (aspetjournals.org [abgerufen am 27. Oktober 2019]).

doi.org

  • J. Germouty, J. L. Jirou-Najou: Clinical Efficacy of Ambroxol in the Treatment of Bronchial Stasis. Clinical Trial in 120 Patients at Two Different Doses. In: Respiration. Band 51, Suppl. 1, 1987, S. 37–41, doi:10.1159/000195273, PMID 3299566 (karger.com [abgerufen am 27. Oktober 2019]).
  • M. Post, J. J. Batenburg, E. A. J. M. Schuurmans, V. Oldenborg, A. J. van der Molen: The perfused rat lung as a model for studies on the formation of surfactant and the effect of Ambroxol on this process. In: Lung. Band 161, Nr. 1, Dezember 1983, S. 349–359, doi:10.1007/BF02713884.
  • Marie-Claude Prevost, Georges Soula, Louis Douste-Blazy: Biochemical Modifications of Pulmonary Surfactant after Bromhexine Derivate Injection. In: Respiration. Band 37, Nr. 4, 1979, S. 215–219, doi:10.1159/000194030 (karger.com [abgerufen am 27. Oktober 2019]).
  • M. F. Heath, W. Jacobson: The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant. In: Lung. Band 163, Nr. 1, 1. Dezember 1985, S. 337–344, doi:10.1007/BF02713834.
  • Zenglin Liao, Jiajia Dong, Wei Wu, Ting Yang, Tao Wang: Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. In: Respiratory Research. Band 13, Nr. 1, 2012, S. 110, doi:10.1186/1465-9921-13-110, PMID 23199346, PMC 3545883 (freier Volltext).
  • Mario Malerba, Beatrice Ragnoli: Ambroxol in the 21st century: pharmacological and clinical update. In: Expert Opinion on Drug Metabolism & Toxicology. Band 4, Nr. 8, 1. August 2008, S. 1119–1129, doi:10.1517/17425255.4.8.1119, PMID 18680446.
  • A. Gillissen, A. Bartling, S. Schoen, G. Schultze-Werninghaus: Antioxidant Function of Ambroxol in Mononuclear and Polymorphonuclear Cells in Vitro. In: Lung. Band 175, Nr. 4, 1. Juli 1997, S. 235–242, doi:10.1007/PL00007570.
  • A. Gillissen, D. Nowak: Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. In: Respiratory Medicine. Band 92, Nr. 4, 1. April 1998, S. 609–623, doi:10.1016/S0954-6111(98)90506-6.
  • Adrian Gillissen, Birgit Schärling, Małgorzata Jaworska, Almut Bartling, Kurt Rasche: Oxidant scavenger function of ambroxol in vitro: a comparison withN-acetylcysteine. In: Research in Experimental Medicine. Band 196, Nr. 1, 1. Dezember 1996, S. 389–398, doi:10.1007/BF02576864.
  • K. Nobata, M. Fujimura, Y. Ishiura, S. Myou, S. Nakao: Ambroxol for the prevention of acute upper respiratory disease. In: Clinical and Experimental Medicine. Band 6, Nr. 2, 1. Juni 2006, S. 79–83, doi:10.1007/s10238-006-0099-2.
  • Giorgio Fois, Nina Hobi, Edward Felder, Andreas Ziegler, Pika Miklavc: A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores. In: Cell Calcium. Band 58, Nr. 6, Dezember 2015, S. 628–637, doi:10.1016/j.ceca.2015.10.002.
  • Alisdair McNeill, Joana Magalhaes, Chengguo Shen, Kai-Yin Chau, Derralyn Hughes, Atul Mehta, Tom Foltynie, J. Mark Cooper, Andrey Y. Abramov, Matthew Gegg, Anthony H. V. Schapira: Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. In: Brain. Band 137, Nr. 5, Mai 2014, S. 1481–1495, doi:10.1093/brain/awu020.
  • Thomas Weiser, Nicola Wilson: Inhibition of Tetrodotoxin (TTX)-Resistant and TTX-Sensitive Neuronal Na+ Channels by the Secretolytic Ambroxol. In: Molecular Pharmacology. Band 62, Nr. 3, 1. September 2002, S. 433–438, doi:10.1124/mol.62.3.433, PMID 12181417 (aspetjournals.org [abgerufen am 27. Oktober 2019]).
  • Andreas Leffler, Jennifer Reckzeh, Carla Nau: Block of sensory neuronal Na+ channels by the secreolytic ambroxol is associated with an interaction with local anesthetic binding sites. In: European Journal of Pharmacology. Band 630, Nr. 1, 25. März 2010, S. 19–28, doi:10.1016/j.ejphar.2009.12.027.
  • Jürgen Fischer, Uwe Pschorn, Jean-Michel Vix, Hubertus Peil, Bernhard Aicher: Efficacy and Tolerability of Ambroxol Hydrochloride Lozenges in Sore Throat. In: Arzneimittelforschung. Band 52, Nr. 4, April 2002, S. 256–263, doi:10.1055/s-0031-1299889.
  • Alexander Schutz, Hans-Jürgen Gund, Uwe Pschorn, Bernhard Aicher, Hubertus Peil: Local Anaesthetic Properties of Ambroxol Hydrochloride Lozenges in View of Sore Throat. In: Arzneimittelforschung. Band 52, Nr. 3, März 2002, S. 194–199, doi:10.1055/s-0031-1299879.
  • Justus Liebigs Annalen der Chemie 707, 107 (1967); J.Keck; Synthese der Metaboliten von Bisolvon; doi:10.1002/jlac.19677070117; Chem. Abstr. 1967:508342.

egms.de

espacenet.com

worldwide.espacenet.com

karger.com

  • J. Germouty, J. L. Jirou-Najou: Clinical Efficacy of Ambroxol in the Treatment of Bronchial Stasis. Clinical Trial in 120 Patients at Two Different Doses. In: Respiration. Band 51, Suppl. 1, 1987, S. 37–41, doi:10.1159/000195273, PMID 3299566 (karger.com [abgerufen am 27. Oktober 2019]).
  • Marie-Claude Prevost, Georges Soula, Louis Douste-Blazy: Biochemical Modifications of Pulmonary Surfactant after Bromhexine Derivate Injection. In: Respiration. Band 37, Nr. 4, 1979, S. 215–219, doi:10.1159/000194030 (karger.com [abgerufen am 27. Oktober 2019]).

kobv.de

opus4.kobv.de

mmp-online.de

nih.gov

ncbi.nlm.nih.gov

  • J. Germouty, J. L. Jirou-Najou: Clinical Efficacy of Ambroxol in the Treatment of Bronchial Stasis. Clinical Trial in 120 Patients at Two Different Doses. In: Respiration. Band 51, Suppl. 1, 1987, S. 37–41, doi:10.1159/000195273, PMID 3299566 (karger.com [abgerufen am 27. Oktober 2019]).
  • C. H. Ericsson, J. Juhász, E. Jönsson, B. Mossberg: Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function. In: European Journal of Respiratory Diseases. Band 69, Nr. 4, Oktober 1986, S. 248–255, PMID 3545883.
  • Zenglin Liao, Jiajia Dong, Wei Wu, Ting Yang, Tao Wang: Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. In: Respiratory Research. Band 13, Nr. 1, 2012, S. 110, doi:10.1186/1465-9921-13-110, PMID 23199346, PMC 3545883 (freier Volltext).
  • Mario Malerba, Beatrice Ragnoli: Ambroxol in the 21st century: pharmacological and clinical update. In: Expert Opinion on Drug Metabolism & Toxicology. Band 4, Nr. 8, 1. August 2008, S. 1119–1129, doi:10.1517/17425255.4.8.1119, PMID 18680446.
  • K. M. Beeh, J. Beier, A. Esperester, L. D. Paul: Antiinflammatory properties of ambroxol. In: European Journal of Medical Research. Band 13, Nr. 12, 3. Dezember 2008, S. 557–562, PMID 19073395.
  • Thomas Weiser, Nicola Wilson: Inhibition of Tetrodotoxin (TTX)-Resistant and TTX-Sensitive Neuronal Na+ Channels by the Secretolytic Ambroxol. In: Molecular Pharmacology. Band 62, Nr. 3, 1. September 2002, S. 433–438, doi:10.1124/mol.62.3.433, PMID 12181417 (aspetjournals.org [abgerufen am 27. Oktober 2019]).

sigmaaldrich.com

unipv.it

iris.unipv.it

web.archive.org